Wassilis S C Bruins
7PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Oct 07, 2025
Immune signatures in older patients with newly diagnosed multiple myeloma are associated with survival outcomes of first-line therapy irrespective of frailty levels.Wassilis S C Bruins, Febe Smits, Carolien Duetz
|Aug 19, 2025
A T-cell-based metric of immune age predicts outcomes in older patients with myeloma receiving daratumumab-based therapy.Wassilis S C Bruins, Febe Smits, Carolien Duetz
|Feb 28, 2025
The bone marrow NK-cell profile predicts MRD negativity in patients with multiple myeloma treated with daratumumab-based therapy.Charlotte L B M Korst, Sabrin Tahri, Carolien Duetz
|Nov 15, 2024
Preclinical evaluation of the CD38-targeting engineered toxin body MT-0169 against multiple myeloma.Wassilis S C Bruins, Rosa Rentenaar, John Newcomb
|Apr 30, 2024
T-Cell Characteristics Impact Response and Resistance to T-Cell-Redirecting Bispecific Antibodies in Multiple Myeloma.Christie P M Verkleij, Chloe A O'Neill, Marloes E C Broekmans
Pageof 2
Frequent Collaborators
4 joint publications
A Vera de Jonge
4 joint publications
Tuna Mutis
4 joint publications
Niels W C J van de Donk
3 joint publications
Rosa Rentenaar
3 joint publications
Charlotte L B M Korst
3 joint publications
Sonja Zweegman
2 joint publications
Pieter Sonneveld
2 joint publications
Giada Dal Collo
2 joint publications
Kristine A Frerichs
1 joint publications
Arnon P Kater
